drugset / Trial / NCT01631903
Extension of Study ZPV-200
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to determine the safety, pharmacokinetics and efficacy of four doses of vaginally administered Proellex in premenopausal women with uterine fibroids confirmed by ultrasound.
Timeline
- Start
- 2012-09
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Proellex | Other / unclassified | 3 mg | Other |
| Subject | Proellex | Other / unclassified | 6 mg | Other |
| Subject | Proellex | Other / unclassified | 12 mg | Other |
| Subject | Proellex | Other / unclassified | 24 mg | Other |